BOURGEON CAPITAL MANAGEMENT LLC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 268 filers reported holding FATE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.

Quarter-by-quarter ownership
BOURGEON CAPITAL MANAGEMENT LLC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$371
-55.5%
1750.0%0.00%
Q2 2023$833
-16.5%
1750.0%0.00%
Q1 2023$998
-43.5%
1750.0%0.00%
Q4 2022$1,766
-55.8%
1750.0%0.00%
-100.0%
Q3 2022$4,0000.0%1750.0%0.00%0.0%
Q2 2022$4,000
-42.9%
1750.0%0.00%
-50.0%
Q1 2022$7,000
-30.0%
1750.0%0.00%0.0%
Q4 2021$10,0000.0%1750.0%0.00%0.0%
Q3 2021$10,000
-33.3%
1750.0%0.00%
-33.3%
Q2 2021$15,000
+7.1%
1750.0%0.00%0.0%
Q1 2021$14,000
-12.5%
1750.0%0.00%
-25.0%
Q4 2020$16,000
+128.6%
1750.0%0.00%
+100.0%
Q3 2020$7,000
+16.7%
1750.0%0.00%0.0%
Q2 2020$6,000
+50.0%
1750.0%0.00%0.0%
Q1 2020$4,000
+33.3%
1750.0%0.00%
+100.0%
Q4 2019$3,000
-81.2%
175
-82.5%
0.00%
-88.9%
Q3 2019$16,000
-83.5%
1,000
-93.5%
0.01%
-83.0%
Q2 2014$97,00015,3840.05%
Other shareholders
FATE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 569,889$46,987,00060.92%
Johnson & Johnson Innovation - JJDC, Inc. 3,379,064$278,604,00036.08%
Darwin Global Management, Ltd. 1,370,133$112,967,00022.12%
Redmile Group, LLC 12,957,222$1,068,323,00015.05%
Copernicus Capital Management, LLC 8,000$660,00010.66%
Casdin Capital, LLC 3,400,000$280,330,0008.35%
Grosvenor Holdings, L.L.C. 1,123,576$92,639,0006.81%
DAFNA Capital Management LLC 314,360$25,919,0006.15%
Ally Bridge Group (NY) LLC 270,000$22,262,0004.27%
Ghost Tree Capital, LLC 185,000$15,253,0003.58%
View complete list of FATE THERAPEUTICS INC shareholders